Quince Therapeutics (QNCX) Earnings Date & Reports

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

QNCX is expected to report earnings to fall 120.83% to -60 cents per share on August 11

Quince Therapeutics QNCX Stock Earnings Reports

Q2'26

Est.

$-0.60

Q1'26

Beat

by $3.04

Q4'25

Missed

by $1.57

Q3'25

Missed

by $0.03

Q2'25

Missed

by $0.08

The last earnings report on May 11 showed earnings per share of $2.88, beating the estimate of -15 cents. With 233.69K shares outstanding, the current market capitalization sits at 18.14M.

View a ticker or compare two or three

Compare

QNCX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for QNCX